ILC Dover Expands Life Sciences Presence with Water for Injection (WFI) and Custom Chemical Solutions
WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP‑1 therapies, and medical devices. LILLINGTON, N.C., May 26, 2026 /PRNewswire/ -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical,...
View original →